Articles tagged "Alcohol"

2021 American Transplant Congress
Serum Phosphatidylethanol is Superior to Urine Ethyl Glucuronide for Diagnosis of Alcohol Relapse in Liver Transplant Recipients
N. Lim¹, T. Leventhal¹, M. Thomson¹, M. Hassan¹, J. Thompson¹, S. Chinnakotla², V. Kirchner², T. Pruett², R. Kandaswamy², V. Humphreville², A. Adams², J. Lake¹
¹Divison of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, MN, ²Divison of Transplantation, University of Minnesota, Minneapolis, MN
*Purpose: Liver transplantation (LT) for alcohol-related liver disease (ALD) is increasing. The primary issue in these patients is often recidivism, therefore screening for ETOH use…
2021 American Transplant Congress
Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis
S. Panchal¹, D. Kaplan², D. Goldberg³, N. Mahmud²
¹Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, ²Gastroenterology, Hospital of the University of Pennsylvania, Philadelphia, PA, ³Gastroenterology, University of Miami Miller School of Medicine, Miami, FL
*Purpose: With the rising proportion of patients receiving liver transplantation for alcoholic hepatitis, it is important to identify methods of ascertaining hospitalizations with alcoholic hepatitis…
2021 American Transplant Congress
Implementation of an Alcohol Screening Program Identifies Active Pre-transplant Drinking and Allows Engagement in Chemical Dependency Treatment
N. Lim¹, T. Leventhal¹, M. Thomson¹, M. Hassan¹, J. Thompson¹, S. Chinnakotla², V. Kirchner², T. Pruett², R. Kandaswamy², V. Humphreville², A. Adams², J. Lake¹
¹Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, MN, ²Division of Transplantation, University of Minnesota, Minneapolis, MN
*Purpose: Alcohol (ETOH) is an important cause of cirrhosis in the US today. Screening patients for ETOH use prior to LT is important to identify…
2021 American Transplant Congress
Serum Phosphatidylethanol is Superior to Urine Ethyl Glucuronide for Detection of Alcohol Use in Pre-transplant Patients
N. Lim¹, T. Leventhal¹, M. Thomson¹, M. Hassan¹, J. Thompson¹, S. Chinnakotla², V. Kirchner², T. Pruett², R. Kandaswamy², V. Humphreville², A. Adams², J. Lake¹
¹Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, MN, ²Division of Transplantation, University of Minnesota, Minneapolis, MN
*Purpose: More patients are presenting for liver transplant (LT) evaluation for alcohol-related liver disease (ALD). Detection of ETOH use has significant implications for patients undergoing…
2020 American Transplant Congress
Healthcare Utilization and Costs of Liver Transplantation for Alcoholic Hepatitis
G. Im¹, A. Vogel¹, S. S. Florman², S. Aqui³, L. Kim-Schluger¹, T. Schiano¹
¹Medicine, Liver Diseases, Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, RMTI, New York, NY, ²Surgery, Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, RMTI, New York, NY, ³Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, RMTI, New York, NY
*Purpose: To determine the healthcare utilization and costs of a liver transplantation (LT) for severe alcoholic hepatitis (AH) program.*Methods: We performed a retrospective healthcare utilization…
2020 American Transplant Congress
IM Naltrexone Post Liver Transplant for Alcoholic Hepatitis Patients to Prevent Relapse
A. Flecha
Transplant Surgery, Montefiore Medical Center, Bronx, NY
*Purpose: The number of patients requiring liver transplants due to Hepatitis C Virus is declining due to the new treatment options, and the growing number…
2020 American Transplant Congress
Alcohol Relapse after Liver Transplant for Alcohol-Related Cirrhosis: A Longitudinal Assessment of Risk Factors for Relapse and Long-Term Survival
B. Rice, N. Mehta, J. L. Dodge, J. D. Grab, C. Sherman
University of California San Francisco, San Francisco, CA
*Purpose: Relapse to alcohol after liver transplant (LT) is common but likely underreported in patients with alcohol-related cirrhosis (AC). The aim of this study was…
2020 American Transplant Congress
A Quality Improvement Project to Reduce the Risk of Alcohol Relapse after Liver Transplantation by Implementing a High-Risk Alcoholism Relapse Scale
R. V. Tholen¹, E. Bundy²
¹Transplant Nephrology, University of Maryland Medical Center, Baltimore, MD, ²School of Nursing, University of Maryland, Baltimore, Baltimore, MD
*Purpose: Alcoholism is the leading cause of liver-related mortality worldwide. Liver transplantation is considered the only curative treatment for end-stage liver disease. Transplantation will reverse…
2020 American Transplant Congress
Effects of Donor Heavy Alcohol Use on Post-Heart Transplant Outcomes: Time to Abstain?
J. Patel, M. Kittleson, D. Chang, E. Kransdorf, D. Geft, A. Shen, K. Nishihara, G. Jamero, L. Czer, F. Esmailian, J. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Donors with a history of heavy alcohol use have been suspected to possibly harbor a subclinical alcoholic cardiomyopathy with limited cardiac reserve. This problem…
2020 American Transplant Congress
Exploring Psychosocial Factors and Disparity in Liver Transplant
K. Schmidt
Dept. of Psychiatry & Behavioral Sciences, Emory University, Atlanta, GA
*Purpose: Trends in liver transplant (LT) have shifted, and increasingly, individuals with alcohol liver disease (ALD) are receiving LT without 6-months of sobriety (Lee &…